Diabetes Education Management
A comparative study on the fear of hypoglycemia and quality of life in patients with type 1 and type 2 diabetes mellitus
Mu Chun, Xu Hongmei, Bao Di, Zhang Fulian, Zhai Yangkui, Xing Qiuling
Published 2021-02-27
Cite as Chin J Diabetes Mellitus, 2021, 13(2): 139-144. DOI: 10.3760/cma.j.cn115791-20200706-00419
Abstract
ObjectiveTo investigate the difference of fear of hypoglycemia (FoH) and quality of life between patients with type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM).
MethodsA total of 21 patients with T1DM and 269 patients with T2DM in Departments of Endocrinology from three tertiary hospitals in Tianjin from February to August, 2019 were investigated by multicenter sampling. Among them, 156 cases (53.8%) were males and 134 cases (46.2%) were females, with an average age of (55.12±9.54) years old. All the subjects were surveyed by the questionnaires including the general information questionnaire, the Chinese version of Hypoglycemia Fear Survey Ⅱ-Worry Scale (CHFSⅡ-WS), the medical outcomes study item short Form health survey (SF-36), and the World Health Organization Five-item Well-Being Index (WHO-5). Kruskal-Wallis H test or Mann-Whitney U test was used for the measurement data, one-way analysis of variance (ANOVA) was used for comparison between groups. Chi-square test was used for statistical data. Multivariate linear regression was used for multivariate analysis.
ResultsThe differences of frequency and type of hypoglycemia between T1DM and T2DM patients were statistically significant (χ²=80.648, P<0.05;χ²=118.856, P<0.05). Scores of CHFSⅡ-WS, WHO-5, physiological function (PF), physical pain (BF), overall health (GH), social function (SF), emotional function (RE), mental health (MH), health change (HT) dimension of SF-36 were significantly different between patients with T1DM and T2DM (allP<0.05). There were significant differences in the scores of PF, SF and HT of CHFSII-WS and SF-36 among the diabetic patients with different types of hypoglycemia (allP<0.05). Multiple linear regression analysis showed that diabetes mellitus type, WHO-5 score, sex, mental health, regular examination and economic status were the independent influencing factors of FoH (partial regression coefficient was -1.621, 0.027, 0.407, -0.010, 0.479, -0.226, allP<0.05).
ConclusionsThe frequency, severity and fear level of FoH in T1DM patients are higher than those in T2DM patients. Hypoglycemia not only increases the fear level of hypoglycemia, but also affects the quality of life and mental health of patients.
Key words:
Diabetes mellitus, type 1; Diabetes mellitus, type 2; Fear of hypoglycemia; Quality of life
Contributor Information
Mu Chun
National Health Commission Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Department of Ophthalmology, Chu Hsien-I Memorial Hospital &
Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin 300134, China
Xu Hongmei
National Health Commission Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Department of Nursing, Chu Hsien-I Memorial Hospital &
Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin 300134,China
Bao Di
National Health Commission Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Department of Infection, Chu Hsien-I Memorial Hospital &
Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin 300134, China
Zhang Fulian
National Health Commission Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Department of Integrated Traditional Chinese Medicine &
Western Medicine, Chu Hsien-I Memorial Hospital &
Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin 300134, China
Zhai Yangkui
National Health Commission Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Department of Integrated Traditional Chinese Medicine &
Western Medicine, Chu Hsien-I Memorial Hospital &
Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin 300134, China
Xing Qiuling
National Health Commission Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Department of Medical Record, Chu Hsien-I Memorial Hospital &
Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin 300134, China